Cell-free circulating tumor DNA in plasma/serum of non-small cell lung cancer.
about
Circulating tumor DNA: a promising biomarker in the liquid biopsy of cancerNon-invasive approaches to monitor EGFR-TKI treatment in non-small-cell lung cancerLiquid biopsy in early stage lung cancerCirculating Tumor Cell and Cell-free Circulating Tumor DNA in Lung CancerCell-free DNA from human plasma and serum differs in content of telomeric sequences and its ability to promote immune response.Clinical potential of gene mutations in lung cancer.Aberrant Protocadherin17 (PCDH17) Methylation in Serum is a Potential Predictor for Recurrence of Early-Stage Prostate Cancer Patients After Radical ProstatectomyAlu methylation serves as a biomarker for non-invasive diagnosis of gliomaCirculating cell-free DNA as a prognostic and predictive biomarker in non-small cell lung cancer.Overcoming crizotinib resistance in ALK-rearranged NSCLC with the second-generation ALK-inhibitor ceritinib.Current status of research and treatment for non-small cell lung cancer in never-smoking females.Comparison of the Amplification Refractory Mutation System, Super Amplification Refractory Mutation System, and Droplet Digital PCR for T790 M Mutation Detection in Non-small Cell Lung Cancer after Failure of Tyrosine Kinase Inhibitor Treatment.Aberrant Promoter Methylation of PCDH17 (Protocadherin 17) in Serum and its Clinical Significance in Renal Cell Carcinoma.Alu hypomethylation and MGMT hypermethylation in serum as biomarkers of glioma.A plasma miRNA signature for lung cancer early detection.Effect of platinum-based chemotherapy on EGFR gene mutation status in lung adenocarcinoma.Analysis of RTEL1 and PCDHGB6 promoter methylation in circulating-free DNA of lung cancer patients using liquid biopsy: A pilot study.A Direct Plasma miRNA Assay for Early Detection and Histological Classification of Lung Cancer.
P2860
Q26746010-3E9CAA9F-502F-4FF4-BF09-94B1263D1BE7Q26801357-32356C34-DBBA-4A73-8745-332F6A533B80Q28065994-643ACD69-D6C7-4963-8ABD-0F48076DA8F0Q28067582-254B6082-EAC2-4086-B2A5-7CBEC25E9795Q33752880-37C546C7-BA61-46EF-8895-FAF0D75939E0Q36316009-74237A04-0D61-4DAF-BEC7-2FC0F48C895FQ36399311-32B5C4FF-ACD8-4B7A-BFB0-ABA49623255DQ37295593-ACA82DDC-7BD2-4B1F-A964-30E49794173DQ37536958-DFDD8A41-4AEA-46B2-990E-E612285AE70CQ38665438-1310940E-88F2-4E95-A52E-86A6753BAC7FQ39298725-3410D574-C94D-4754-B683-886AAD87EF8BQ40502030-C4E7EF38-E05A-4EFF-A9D3-577CE0076DD5Q41035533-DCF8E8F7-E795-41C6-8C44-67FB2242B753Q47110506-ACFFAA37-AD09-46F0-819A-9EE747ECE6DDQ47562355-EC020878-225E-49B0-BE98-496FAB8F964FQ49210549-ADEC1F97-CB8F-4177-8573-A8514E0AA0B2Q51477838-F15DEF08-A75D-45E2-A442-BA89F79D5BB9Q55691041-4EAA7719-ECD6-4DA1-BE71-ACBE9E307839
P2860
Cell-free circulating tumor DNA in plasma/serum of non-small cell lung cancer.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Cell-free circulating tumor DNA in plasma/serum of non-small cell lung cancer.
@en
type
label
Cell-free circulating tumor DNA in plasma/serum of non-small cell lung cancer.
@en
prefLabel
Cell-free circulating tumor DNA in plasma/serum of non-small cell lung cancer.
@en
P2093
P2860
P1433
P1476
Cell-free circulating tumor DNA in plasma/serum of non-small cell lung cancer.
@en
P2093
P2860
P2888
P356
10.1007/S13277-014-2758-3
P577
2014-10-29T00:00:00Z
P6179
1022618241